AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A federal watchdog will take on Medicare scams; Belviq, a weight loss drug, has been pulled from market; issues at Veterans Affairs have resulted in healthcare roadblocks.

Researchers describe results of carfilizomib and bendamustine in a phase 1/2 study.

China reported a sharp uptick in coronavirus cases; a Massachusetts lawsuit claims Juul advertisements targeted children; motion picture technology is being used in rehab centers.

Cancer drug trials often do not report on cardiovascular outcomes; CVS is investing in affordable housing to reduce overall healthcare costs; a drug for obsessive compulsive disorder that was developed through artificial intelligence will soon be tested in humans.

The 2021 budget request from the Trump administration involves budget cuts for agencies such as HHS, CDC, and the Environmental Protection Agency; an investigational treatment for Alzheimer disease failed to slow or stop cognitive decline in patients involved in an international clinical trial; CDC confirmed a new case of coronavirus in San Diego, California.

The reported death toll of the coronavirus in China has exceeded that of the SARS crisis from 17 years ago; the Trump administration delayed a signature healthcare initiative aiming to increase dialysis at home and transplants for US kidney patients; nearly 170 organs could not be transplanted due to transportation issues on commercial flights.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A study shows young adults prefer short-term perks to long-term benefits; $4 million has been stolen from Mississippi's welfare fund; Los Angeles has reported 5 confirmed cases of measles.

The Patent Trial and Appeals Board delivered a setback to Gilead Sciences, rejecting its attempt to invalidate a pair of Truvada patents owned by the CDC; Merck is spinning off some businesses in order to focus on its oncology drug pembrolizumab, including its biosimilars operations; Republican and Democratic governors are worried that a proposed CMS fiscal accountability rule for Medicaid will reduce access to healthcare.

The FDA reexamines asbestos testing for talc powders and cosmetics; elderly patients with HIV have high polypharmacy use; the government issues an emergency use authorization for a coronavirus diagnostic.

The FDA launched a mobile-friendly, interactive database providing information on eligible HIV antiretroviral treatments available; an HIV vaccine trial by Fred Hutchinson Cancer Research Center ended after failing to provide protection from the virus; New Jersey Governor Phil Murphy established a coronavirus task force to manage the state’s preparedness and response to the virus.

The US declares a public health emergency over the coronavirus outbreak; the FDA approves the first treatment for peanut allergy in children, sold as Palforzia; the Trump administration rejects California's healthcare tax on managed care organizations.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

The World Health Organization issued a global health emergency over coronavirus; a judge orders Johnson & Johnson to pay hundreds of millions in a pelvic mesh suit; the House of Representatives passes a ban on fentanyl look-alikes.

The newly sworn in FDA commissioner faces tobacco regulation challenges; CMS announces changes in hospital quality ratings; soldiers with traumatic brain injuries are more likely to develop mental health disorders.

HHS will announce its Medicaid fixed-payment block grant proposal on Thursday; the United States reiterates its offer to send a team to China to help with the coronavirus outbreak; Maryland legislators renew their fight over medically assisted suicide.

The American Medical Association Foundation announced a national fellowship program to promote best practices and shared outcomes for the LGBTQ community; the FDA issued guidances promoting development of gene therapy products; the CDC announces 110 possible cases of coronavirus in the United States.

Chinese health authorities are testing an HIV drug, lopinavir and ritonavir, as a potential treatment for the new coronavirus; a debate is growing over the efficacy of the sole drug approved to prevent preterm birth; the Trump administration threatens to withhold Califonia’s federal funding due to its abortion coverage requirements.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A pharmaceutical company executive is sentenced for his role in the opioid crisis; the CDC confirms the second US case of the Chinese coronavirus; the FDA issues accelerated approval of Tazverik for epithelioid sarcoma.

A group of 18 health plans announce they will manufacture generic drugs; President Trump hints at cutting Medicare funding; the Chinese government quarantines a city of 11 million in an effort to stop the spread of the coronavirus.

The FDA gives marketing approval for a test that screens for Duchenne muscular dystrophy in newborns; acetaminophen is facing a possible statewide ban in California; the Supreme Court will not rush its decision on the Affordable Care Act.

President Trump grew frustrated with HHS Secretary Alex Azar over healthcare polling and vaping involvement; a top Chinese scientist confirms that humans can transmit new coronavirus; coal plant closures were shown to save over 26,000 lives from 2005 to 2016.

The CDC announced it will screen for the emerging coronavirus from China in 3 US airports; the US birth rate is at an all-time low; tech giants strike deals with hospitals to access millions of medical records.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Along with weight loss, exercise, and nutrition, employers now target sleep improvements in employees; a Republican member of the FTC supports Medicare drug price negotiations; sepsis is likely responsible for 20% of deaths worldwide.

Since 2016, racial and ethnic healthcare disparities have not improved; a new method of "reanimating" hearts from recently deceased donors for transplants is being tested; the new decade prompts concerns about an aging population.

Physician burnout continues to be pervasive and differs by generation; more opioid doses flooded the market than originally believed; the FDA drug approval rate is speeding up.

Oklahoma is suing 3 major opioid manufacturers for their role in the opioid epidemic; first responders and other workers exposed to carcinogens during 9/11 found to have an elevated incidence of leukemia; cost of MS treatments determine patient financial decisions.